Antibiotics vs cancer survival — After adjusting for tumour spread, cancer site, age, sex, comorbidity, antibiotic exposure within 180 days before non-ICI systemic therapy caused lower survival (HR from 1.21 to 1.58 for shorter periods since antibiotics) h
Antibiotic use vs survival of cancer patients treated with immune checkpoint inhibitors —Antibiotics associated with poor survival outcomes, including overall survival (HR=1.94; 1.68/2.25; p <0.001) & rogression-free survival (HR=1.83; 1.53/2.19; p
New article: The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors https://t.co/WqYijDmZka #kidneycancer #oncology https://t.co/LrmUSnUVH1
The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors: Background Nowadays, immune checkpoint inhibitors (ICIs) have become one of the essential #immunology… https://t.co/RoOiR